Cleared Traditional

K052142 - QUANTA LITE GLIADIN IGG II (FDA 510(k) Clearance)

Oct 2005
Decision
57d
Days
Class 2
Risk

K052142 is an FDA 510(k) clearance for the QUANTA LITE GLIADIN IGG II. This device is classified as a Antibodies, Gliadin (Class II - Special Controls, product code MST).

Submitted by Inova Diagnostics, Inc. (San Diego, US). The FDA issued a Cleared decision on October 4, 2005, 57 days after receiving the submission on August 8, 2005.

This device falls under the Immunology FDA review panel. Regulated under 21 CFR 866.5750.

Submission Details

510(k) Number K052142 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 08, 2005
Decision Date October 04, 2005
Days to Decision 57 days
Submission Type Traditional
Review Panel Immunology (IM)
Summary Statement

Device Classification

Product Code MST — Antibodies, Gliadin
Device Class Class II - Special Controls
CFR Regulation 21 CFR 866.5750